CD4 and cancer: Our data suggest these prognostic markers have predictive value for risk of virus-associated cancers over a 6- to 8-year window prior to diagnosis; a subset of cases had chronically low CD4 and/or low CD8 counts as long as 10 years or longer prior to diagnosis (Fig. 1).